Back to Top
Tafasitamab Biosimilar - Research Grade
Add recommended extras
Tafasitamab Biosimilar - Research Grade
| Species Reactivity | Human |
|---|---|
| Target | CD19 |
| Concentration | 5mg/ml |
| Isotype | Human IgG1 (S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M)-Kappa |
| Host | CHO Cells |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Application Notes | This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients. |
| Applications | Functional Assays |
| Storage | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
| Endotoxin | <1EU/mg Determined by LAL gel clotting assay |
| Purity | ≥95% monomer by analytical SEC, >95% by SDS Page |
| Formulation | Sterile, preservative-free, solution in PBS. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human CD19 |
| Shipping Conditions | Blue ice |
| background | Uses the same sequence as the therapeutic antibody Tafasitamab |
| Other names | B4, CVID3, Leu-12 |
| Buffer | ICH3002 |
| Sequence | https://www.imgt.org/mAb-DB/ |
Write Your Own Review
Who Viewed This Also Viewed
